Search research articles
Contact Us
Filters
Showing results (1-10 of 36) with videos related to
Page
of 4
Sort By:
Cancer Investigation
|
April 9, 2005
Preclinical and clinical experience with fulvestrant (Faslodex) in postmenopausal women with hormone receptor-positive advanced breast cancer
Nigel Bundred
Clinical Evidence
|
January 18, 2005
Breast pain
Nigel Bundred
Clinical Evidence
|
February 27, 2003
Breast pain
Nigel Bundred
Clinical Evidence
|
April 20, 2006
Breast pain
Nigel Bundred
Clinical Evidence
|
September 2, 2005
Breast pain
Nigel Bundred
Clinical Evidence
|
September 17, 2002
Breast pain
Nigel Bundred
Cancer Treatment Reviews
|
February 29, 2012
Antiresorptive therapies in oncology and their effects on cancer progression
Nigel Bundred
Clinical Evidence
|
November 24, 2004
Breast pain
Nigel Bundred
British Journal of Hospital Medicine (London, England : 2005)
|
August 22, 2006
The evolving role of exemestane in the management of breast cancer
Nigel Bundred
Seminars in Oncology
|
December 11, 2007
Reducing the risk of cancer treatment-associated bone loss in patients with breast cancer
Peyman Hadji, Nigel Bundred
Page
of 4
Search research articles
Search
Showing results (1-10 of 36) with videos related to
Sort By:
Page
of 4
Cancer Investigation
|
April 9, 2005
Preclinical and clinical experience with fulvestrant (Faslodex) in postmenopausal women with hormone receptor-positive advanced breast cancer
Nigel Bundred
Clinical Evidence
|
January 18, 2005
Breast pain
Nigel Bundred
Clinical Evidence
|
February 27, 2003
Breast pain
Nigel Bundred
Clinical Evidence
|
April 20, 2006
Breast pain
Nigel Bundred
Clinical Evidence
|
September 2, 2005
Breast pain
Nigel Bundred
Clinical Evidence
|
September 17, 2002
Breast pain
Nigel Bundred
Cancer Treatment Reviews
|
February 29, 2012
Antiresorptive therapies in oncology and their effects on cancer progression
Nigel Bundred
Clinical Evidence
|
November 24, 2004
Breast pain
Nigel Bundred
British Journal of Hospital Medicine (London, England : 2005)
|
August 22, 2006
The evolving role of exemestane in the management of breast cancer
Nigel Bundred
Seminars in Oncology
|
December 11, 2007
Reducing the risk of cancer treatment-associated bone loss in patients with breast cancer
Peyman Hadji, Nigel Bundred
Page
of 4